Key points • Cardiovascular diseases (CVDs) are primary contributors to both disability and early death in sub‐Saharan Africa. Most of the current blood tests for CVD diagnosis involve performing about three test profiles often at additional cost to patients. • C‐peptide, a product of proinsulin, could potentially serve as a proxy marker for diagnosing CVDs in resource‐poor settings. • The sensitivity and specificity of C‐peptide in identifying CVD in this study were 96.1% and 91.3%, respectively (area under the curve = 0.938, p < 0.001).
All Keywords
【저자키워드】 Inflammation, cardiovascular disease, diabetes, insulin resistance, C‐peptide,
【저자키워드】 Inflammation, cardiovascular disease, diabetes, insulin resistance, C‐peptide,